Abstract
5.21 ROR1-Immunotoxin as a Potential Therapeutic Agent for Certain Human B-cell Malignancies Sivasubramanian Baskar, Adrian Wiestner, Wyndham H. Wilson, Ira Pastan, Christoph Rader Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute; Hematology Branch, National Heart, Lung and Blood Institute and Metabolism Branch, Center for Cancer Research, National Cancer Institute; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
